Gaillard S, Oaknin A, Ray-Coquard I, Vergote I, et al. Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL). Gynecol Oncol 2021 Sep 11. pii: S0090-8258(21)01330.
PMID: 34521554